NeuroOne Medical Technologies (NeuroOne Medical Technologies) Days Sales Outstanding : 50.66 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is NeuroOne Medical Technologies Days Sales Outstanding?

NeuroOne Medical Technologies's average Accounts Receivable for the three months ended in Dec. 2023 was $0.54 Mil. NeuroOne Medical Technologies's Revenue for the three months ended in Dec. 2023 was $0.98 Mil. Hence, NeuroOne Medical Technologies's Days Sales Outstanding for the three months ended in Dec. 2023 was 50.66.

The historical rank and industry rank for NeuroOne Medical Technologies's Days Sales Outstanding or its related term are showing as below:

NMTC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 6.17 Med: 86.45 Max: 98.43
Current: 36.81

During the past 13 years, NeuroOne Medical Technologies's highest Days Sales Outstanding was 98.43. The lowest was 6.17. And the median was 86.45.

NMTC's Days Sales Outstanding is ranked better than
86.99% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.94 vs NMTC: 36.81

NeuroOne Medical Technologies's Days Sales Outstanding declined from Dec. 2022 (50.78) to Dec. 2023 (50.66).

NeuroOne Medical Technologies Days Sales Outstanding Historical Data

The historical data trend for NeuroOne Medical Technologies's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeuroOne Medical Technologies Days Sales Outstanding Chart

NeuroOne Medical Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Days Sales Outstanding

Get a 7-Day Free Trial

98.43

86.45

6.17

NeuroOne Medical Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															50.78	30.25	31.00	-	50.66

Competitive Comparison of NeuroOne Medical Technologies's Days Sales Outstanding

For the Medical Devices subindustry, NeuroOne Medical Technologies's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NeuroOne Medical Technologies's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NeuroOne Medical Technologies's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where NeuroOne Medical Technologies's Days Sales Outstanding falls into.

NeuroOne Medical Technologies Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

NeuroOne Medical Technologies's Days Sales Outstanding for the fiscal year that ended in Sep. 2023 is calculated as

	Days Sales Outstanding (A: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2022 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (0.033	+	0)	/	1 )	/	1.952	*	365
=	0.033					/	1.952	*	365
=	6.17

NeuroOne Medical Technologies's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0.543)	/	1 )	/	0.978	*	365 / 4
=	0.543					/	0.978	*	365 / 4
=	50.66

NeuroOne Medical Technologies (NAS:NMTC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

NeuroOne Medical Technologies Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of NeuroOne Medical Technologies's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

NeuroOne Medical Technologies (NeuroOne Medical Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NeuroOne Medical Technologies Corp (NAS:NMTC) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

7599 Anagram Dr., Eden Prairie, MN, USA, 55344

Website

https://www.n1mtc.com

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Executives

Mark Christianson	10 percent owner, officer: VP, Business Dev and Marketing	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347
Ronald W. Mcclurg	officer: Chief Financial Officer	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
David A Rosa	director, officer: CEO and President	10901 RED CIRCLE DRIVE, SUITE 150, MINNETONKA MN 55343
Hijaz Haris	officer: VP of Marketing	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DR, EDEN PRAIRIE MN 55344
Morgan C. Frank	10 percent owner	2 CALLE NAIRN, UNIT 701, SAN JUAN PR 00907
Manchester Management Co Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02110
Manchester Explorer, L.p.	10 percent owner	MANCHESTER MANAGEMENT COMPANY, L.L.C, 3 WEST HILL PLACE, Boston ma 02114
James E Besser	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114
Manchester Management Pr, Llc	10 percent owner	3 WEST HILL PLACE, BOSTON MA 02114
Edward Andrle	director	C/O NEUROONE MEDICAL TECHNOLOGIES CORP, 7599 ANAGRAM DRIVE, EDEN PRAIRIE MN 55344
Wade Fredrickson	10 percent owner	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347
Steve Mertens	officer: Chief Technology Officer	10901 RED CIRCLE DR., SUITE 150, MINNETONKA MN 55343
Scott Heuler	officer: Vice President of Sales	10901 RED CIRCLE DR., SUITE 150, MINNETONKA MN 55343
Paul Buckman	director	12988 VALLEY VIEW RD, EDEN PRAIRIE MN 55402
Suraj Kalia	director	10006 LIATRIS LANE, EDEN PRAIRIE MN 55347